Found: 95
Select item for more details and to access through your institution.
Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1267, doi. 10.1007/s10637-015-0297-4
- By:
- Publication type:
- Article
Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxicities.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 2066, doi. 10.1007/s10637-012-9796-8
- By:
- Publication type:
- Article
A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 6, p. 361, doi. 10.1002/gcc.23127
- By:
- Publication type:
- Article
Management of Painful Pelvic Bone Metastasis of Renal Cell Carcinoma Using Embolization, Radio-frequency Ablation, and Cementoplasty: A Prospective Evaluation of Efficacy and Safety.
- Published in:
- CardioVascular & Interventional Radiology, 2014, v. 37, n. 3, p. 730, doi. 10.1007/s00270-013-0740-x
- By:
- Publication type:
- Article
Validation of a deep learning segmentation algorithm to quantify the skeletal muscle index and sarcopenia in metastatic renal carcinoma.
- Published in:
- European Radiology, 2022, v. 32, n. 7, p. 4728, doi. 10.1007/s00330-022-08579-9
- By:
- Publication type:
- Article
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 261, doi. 10.1007/s00262-010-0935-9
- By:
- Publication type:
- Article
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 1, p. 17, doi. 10.3390/cells11010017
- By:
- Publication type:
- Article
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
- Published in:
- BJU International, 2021, v. 128, n. 2, p. 254, doi. 10.1111/bju.15356
- By:
- Publication type:
- Article
Patient‐reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
- Published in:
- BJU International, 2020, v. 126, n. 1, p. 73, doi. 10.1111/bju.15058
- By:
- Publication type:
- Article
Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2018, v. 121, n. 2, p. 203, doi. 10.1111/bju.13855
- By:
- Publication type:
- Article
Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib.
- Published in:
- BJU International, 2016, v. 118, n. 6, p. 890, doi. 10.1111/bju.13585
- By:
- Publication type:
- Article
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 744, doi. 10.1111/bju.12845
- By:
- Publication type:
- Article
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.
- Published in:
- BJU International, 2015, v. 115, n. 1, p. 65, doi. 10.1111/bju.12552
- By:
- Publication type:
- Article
Lung Cancer and Renal Insufficiency: Prevalence and Anticancer Drug Issues.
- Published in:
- Lung, 2009, v. 187, n. 1, p. 69, doi. 10.1007/s00408-008-9123-5
- By:
- Publication type:
- Article
Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours.
- Published in:
- Oncogene, 1998, v. 16, n. 23, p. 3083, doi. 10.1038/sj.onc.1202096
- By:
- Publication type:
- Article
Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195042
- By:
- Publication type:
- Article
Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.671969
- By:
- Publication type:
- Article
Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit.
- Published in:
- Annals of Intensive Care, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13613-020-00761-w
- By:
- Publication type:
- Article
Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Metastatic Renal Cell Carcinoma: Relationship Between Initial Metastasis Hypoxia, Change After 1 Month's Sunitinib, and Therapeutic Response: An <sup>18</sup>F-Fluoromisonidazole PET/CT Study.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 7, p. 1048, doi. 10.2967/jnumed.110.084517
- By:
- Publication type:
- Article
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7649, doi. 10.3390/ijms23147649
- By:
- Publication type:
- Article
Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 20, p. 1454, doi. 10.1093/jnci/djn319
- By:
- Publication type:
- Article
Mitochondria-bound hexokinase as target for therapy of malignant gliomas.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 2, p. 216, doi. 10.1002/ijc.2910620218
- By:
- Publication type:
- Article
Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221100022
- By:
- Publication type:
- Article
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 434, doi. 10.1038/s41416-023-02513-6
- By:
- Publication type:
- Article
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 1, p. 73, doi. 10.1038/s41416-023-02492-8
- By:
- Publication type:
- Article
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 518, doi. 10.1007/s12325-021-01885-6
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rechallenge with mTOR Inhibitors in Metastatic Renal Cell Carcinoma Patients Who Progressed on Previous mTOR Inhibitor Therapy.
- Published in:
- Oncology, 2013, v. 85, n. 1, p. 8, doi. 10.1159/000350005
- By:
- Publication type:
- Article
New Insights into the Management of Renal Cell Cancer.
- Published in:
- Oncology, 2012, v. 84, n. 1, p. 22, doi. 10.1159/000342962
- By:
- Publication type:
- Article
Epoetin β Once-Weekly Therapy in Anemic Patients with Solid Tumors and Non-Myeloid Hematological Malignancies Receiving Chemotherapy.
- Published in:
- Oncology, 2008, v. 74, n. 1/2, p. 112, doi. 10.1159/000139139
- By:
- Publication type:
- Article
Comment faire progresser les connaissances sur la toxicité des immunothérapies en 2024 ?
- Published in:
- Revue Immunite & Cancer, 2023, v. 7, n. 4, p. 159
- By:
- Publication type:
- Article
Carcinomes rénaux à cellules chromophobes – Quelle place pour les traitements systémiques ?
- Published in:
- Revue Immunite & Cancer, 2022, v. 6, n. 4, p. 177
- By:
- Publication type:
- Article
Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 22, p. 1729, doi. 10.1093/jnci/djt280
- By:
- Publication type:
- Article
Outcomes in elderly patients admitted to the intensive care unit with solid tumors.
- Published in:
- Annals of Intensive Care, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13613-017-0250-0
- By:
- Publication type:
- Article
Signification et intérêt clinique de l'expression de PD-1 et PDL-1 dans les tumeurs.
- Published in:
- Médecine Sciences, 2013, v. 29, n. 6/7, p. 570, doi. 10.1051/medsci/2013296005
- By:
- Publication type:
- Article
DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries.
- Published in:
- Prostate, 2022, v. 82, n. 12, p. 1196, doi. 10.1002/pros.24374
- By:
- Publication type:
- Article
Post Hoc Health‐Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1179, doi. 10.1002/onco.13803
- By:
- Publication type:
- Article
Indocyanine green for sentinel lymph node detection in early breast cancer: Prospective evaluation of detection rate and toxicity—The FLUOBREAST trial.
- Published in:
- Breast Journal, 2020, v. 26, n. 12, p. 2357, doi. 10.1111/tbj.14100
- By:
- Publication type:
- Article
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1025, doi. 10.1007/s40262-024-01396-x
- By:
- Publication type:
- Article
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clearcell renal cell carcinoma.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 4, p. 498, doi. 10.1080/0284186X.2017.1388927
- By:
- Publication type:
- Article
Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 10, p. 1413, doi. 10.3109/0284186X.2014.918276
- By:
- Publication type:
- Article
Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042252
- By:
- Publication type:
- Article
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 2, p. 345, doi. 10.1007/s00345-022-04253-3
- By:
- Publication type:
- Article
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 5, p. 1377, doi. 10.1007/s00345-020-03528-x
- By:
- Publication type:
- Article
Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 5, p. 1421, doi. 10.1007/s00345-020-03328-3
- By:
- Publication type:
- Article
Biomarkers from the tumor microenvironment to predict clinical response to checkpoint inhibitors.
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 4, p. 117, doi. 10.13032/tjop.2052-5931.100111.
- By:
- Publication type:
- Article
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma ( RCC) treated with sunitinib.
- Published in:
- BJU International, 2014, v. 114, n. 1, p. 81, doi. 10.1111/bju.12494
- By:
- Publication type:
- Article